Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets

Amgen Deferred Tax Assets and Other Non-Current Assets increased by 0.8% to $12.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $11.39B to $12.76B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 17.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024

How to read this metric

An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.

Detailed definition

This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...

Peer comparison

Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.

Metric ID: deferred_tax_assets_other_noncurrent

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.78B$6.31B$6.52B$6.07B$6.02B$6.34B$5.90B$7.63B$7.19B$7.84B$9.61B$9.01B$8.82B$10.38B$9.93B$11.39B$11.02B$13.22B$12.66B$12.76B
QoQ Change+9.0%+3.4%-7.0%-0.8%+5.3%-6.9%+29.4%-5.8%+8.9%+22.7%-6.3%-2.1%+17.8%-4.4%+14.7%-3.2%+20.0%-4.2%+0.8%
YoY Change+4.1%+0.5%-9.6%+25.7%+19.4%+23.6%+62.9%+18.0%+22.6%+32.5%+3.3%+26.4%+25.0%+27.3%+27.5%+12.0%
Range$5.78B$13.22B
CAGR+18.1%
Avg YoY Growth+20.1%
Median YoY Growth+23.1%

Frequently Asked Questions

What is Amgen's deferred tax assets and other non-current assets?
Amgen (AMGN) reported deferred tax assets and other non-current assets of $12.76B in Q1 2026.
How has Amgen's deferred tax assets and other non-current assets changed year-over-year?
Amgen's deferred tax assets and other non-current assets increased by 12.0% year-over-year, from $11.39B to $12.76B.
What is the long-term trend for Amgen's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Amgen's deferred tax assets and other non-current assets has grown at a 17.6% compound annual growth rate (CAGR), from $5.64B to $12.66B.
What does deferred tax assets and other non-current assets mean?
The total value of long-term tax assets and other miscellaneous long-term assets.